Adult T-cell leukaemia-lymphoma (ATL) is a malignancy of peripheral T lymphocytes caused
by human T-lymphotropic virus type I (HTLV-1), and its prognosis is poor. There are an …

Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell
leukemia virus type I (HTLV-1) infection and often occurs in HTLV-1-endemic areas, such as …

Purpose Adult T-cell leukemia-lymphoma (ATL) is a distinct mature T-cell malignancy
caused by chronic infection with human T-lymphotropic virus type 1 with diverse clinical …

Definitive risk factors for the development of adult T-cell leukemia (ATL) among
asymptomatic human T-cell leukemia virus type I (HTLV-1) carriers remain unclear …

HTLV-1 (Human T-cell lymphotropic virus type 1) is a complex human delta retrovirus that
currently infects 10–20 million people worldwide. While HTLV-1 infection is generally …

After cell-to-cell transmission, HTLV-I increases its viral genome by de novo infection and
proliferation of infected cells. Proliferation of infected cells is clonal and persistent in vivo …

It has been nearly 40 years since human T-cell leukemia virus-1 (HTLV-1), the first
oncogenic retrovirus in humans and the first demonstrable cause of cancer by an infectious …

The clinical entity of adult T-cell leukemia (ATL) was established around 1977, and human T-
cell leukemia virus type 1 (HTLV-I) was subsequently identified in 1980. In the 25 years …

The human T cell leukemia virus type 1 (HTLV-1) is a pathogenic retrovirus that persists as a
provirus in the genome of infected cells and can lead to adult T cell leukemia (ATL) …

Background Human T-lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated
with both HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), which is a …